Lidocaine and Magnesium and Ketamine in Gynecological Surgery
NCT04622904 · annie-sophia · Aretaieion University Hospital
What it is testing
Summary
Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.
What counts as success
Primary outcome measures
change from baseline in Quality of Recovery (QoR)-15 score after surgery
Measured over 24 hours postoperatively
pain score on arrival to Post-Anesthesia Care Unit (PACU)
Measured over immediately postoperatively
pain score at discharge from Post-Anesthesia Care Unit (PACU)
Measured over at discharge from PACU, approximately 1 h postoperatively
pain score 3 hours postoperatively
Measured over 3 hours postoperatively
pain score 6 hours postoperatively
Measured over 6 hours postoperatively
pain score 24 hours postoperatively
Measured over 24 hours postoperatively
pain score 48 hours postoperatively
Measured over 48 hours postoperatively
A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.
Who can take part
Eligibility, as published
Where
1 study site
| Facility | City | Region | Country |
|---|---|---|---|
| Aretaieion University Hospital | Athens | — | Greece |
On the registry
Contact the trial directly
This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.
Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.
NCT04622904 on ClinicalTrials.gov →
Last updated in the registry 2022-10-27. Registry records change; this page reflects the data build of 2026-08-25.
Related